These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1309489)

  • 1. Newly synthesized class II MHC chains are required for VSV G presentation to CTL clones.
    Reiss CS; Gapud CP; Keil W
    Cell Immunol; 1992 Jan; 139(1):229-38. PubMed ID: 1309489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytolytic T lymphocytes from the BALB/c-H-2dm2 mouse recognize the vesicular stomatitis virus glycoprotein and are restricted by class II MHC antigens.
    Browning MJ; Huang AS; Reiss CS
    J Immunol; 1990 Aug; 145(3):985-94. PubMed ID: 1695651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The soluble viral glycoprotein of vesicular stomatitis virus efficiently sensitizes target cells for lysis by CD4+ T lymphocytes.
    Browning M; Reiss CS; Huang AS
    J Virol; 1990 Aug; 64(8):3810-6. PubMed ID: 2164598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-gamma-induced recognition of the antigen-processing variant CMT.64 by cytolytic T cells can be replaced by sequential addition of beta 2 microglobulin and antigenic peptides.
    Jefferies WA; Kolaitis G; Gabathuler R
    J Immunol; 1993 Sep; 151(6):2974-85. PubMed ID: 8397249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhanced presentation of major histocompatibility complex class I-restricted human immunodeficiency virus type 1 (HIV-1) Gag-specific epitopes after DNA immunization with vectors coding for vesicular stomatitis virus glycoprotein-pseudotyped HIV-1 Gag particles.
    Marsac D; Loirat D; Petit C; Schwartz O; Michel ML
    J Virol; 2002 Aug; 76(15):7544-53. PubMed ID: 12097567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antigen processing mutant T2 cells present viral antigen restricted through H-2Kb.
    Zhou X; Glas R; Liu T; Ljunggren HG; Jondal M
    Eur J Immunol; 1993 Aug; 23(8):1802-8. PubMed ID: 8393799
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of de novo protein synthesis in target cells recognized by cytotoxic T lymphocytes specific for vesicular stomatitis virus.
    Roscoe DM; Ishikawa K; Lyles DS
    J Virol; 1991 Dec; 65(12):6856-61. PubMed ID: 1658379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatitis B virus (HBV)-specific cytotoxic T-cell (CTL) response in humans: characterization of HLA class II-restricted CTLs that recognize endogenously synthesized HBV envelope antigens.
    Penna A; Fowler P; Bertoletti A; Guilhot S; Moss B; Margolskee RF; Cavalli A; Valli A; Fiaccadori F; Chisari FV
    J Virol; 1992 Feb; 66(2):1193-8. PubMed ID: 1731098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TAP2-defective RMA-S cells present Sendai virus antigen to cytotoxic T lymphocytes.
    Zhou X; Glas R; Momburg F; Hämmerling GJ; Jondal M; Ljunggren HG
    Eur J Immunol; 1993 Aug; 23(8):1796-801. PubMed ID: 8393798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition by brefeldin A of presentation of exogenous protein antigens to MHC class II-restricted T cells.
    Adorini L; Ullrich SJ; Appella E; Fuchs S
    Nature; 1990 Jul; 346(6279):63-6. PubMed ID: 2366863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigen-presenting B cells: efficient uptake and presentation by activated B cells for induction of cytotoxic T lymphocytes against vesicular stomatitis virus.
    Ciavarra RP; Burgess DH
    Cell Immunol; 1988 Jun; 114(1):27-40. PubMed ID: 2836071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathways of viral antigen processing and presentation to CTL: defined by the mode of virus entry?
    Long EO; Jacobson S
    Immunol Today; 1989 Feb; 10(2):45-8. PubMed ID: 2665772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presentation of viral antigens restricted by H-2Kb, Db or Kd in proteasome subunit LMP2- and LMP7-deficient cells.
    Zhou X; Momburg F; Liu T; Abdel Motal UM; Jondal M; Hämmerling GJ; Ljunggren HG
    Eur J Immunol; 1994 Aug; 24(8):1863-8. PubMed ID: 8056044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brefeldin A specifically inhibits presentation of protein antigens to cytotoxic T lymphocytes.
    Yewdell JW; Bennink JR
    Science; 1989 Jun; 244(4908):1072-5. PubMed ID: 2471266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell hybridomas define the class II MHC-restricted response to vesicular stomatitis virus infection.
    Petrarca MA; Reiss CS; Diamond DC; Boni J; Burakoff SJ; Faller DV
    Microb Pathog; 1988 Nov; 5(5):319-32. PubMed ID: 2853279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. VSV G protein induces murine cytolytic T lymphocytes.
    Reiss CS; Chen SS; Huang AS; Doherty R
    Microb Pathog; 1986 Jun; 1(3):261-7. PubMed ID: 2854599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Class II MHC-restricted T cell determinants processed from either endosomes or the cytosol show similar requirements for host protein transport but different kinetics of presentation.
    Hackett CJ; Yewdell JW; Bennink JR; Wysocka M
    J Immunol; 1991 May; 146(9):2944-51. PubMed ID: 1673146
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Class II MHC molecules can use the endogenous pathway of antigen presentation.
    Nuchtern JG; Biddison WE; Klausner RD
    Nature; 1990 Jan; 343(6253):74-6. PubMed ID: 1967486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral immune responses of mice lacking MHC class II or its associated invariant chain.
    Battegay M; Bachmann MF; Burhkart C; Viville S; Benoist C; Mathis D; Hengartner H; Zinkernagel RM
    Cell Immunol; 1996 Jan; 167(1):115-21. PubMed ID: 8548834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The predominance of CD8+ T cells after infection with measles virus suggests a role for CD8+ class I MHC-restricted cytotoxic T lymphocytes (CTL) in recovery from measles. Clonal analyses of human CD8+ class I MHC-restricted CTL.
    van Binnendijk RS; Poelen MC; Kuijpers KC; Osterhaus AD; Uytdehaag FG
    J Immunol; 1990 Mar; 144(6):2394-9. PubMed ID: 2107259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.